Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RUBY - Arcturus Progresses ARCT-810 Trial And Other News: The Good Bad And Ugly Of Biopharma

RUBY - Arcturus Progresses ARCT-810 Trial And Other News: The Good Bad And Ugly Of Biopharma

Rubius Therapeutics Inc.
  • Arcturus Therapeutics progresses ARCT-810 trial, inks new ARCT-021 collaboration.
  • ALX Oncology provides updates for ALX148 study in myelodysplastic syndrome.
  • Rubius Therapeutics reports positive data for HPV-positive cancers therapy.

For further details see:

Arcturus Progresses ARCT-810 Trial, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Rubius Therapeutics Inc.
Stock Symbol: RUBY
Market: NASDAQ
Website: rubiustx.com
Menu
RUBY RUBY Quote RUBY Short RUBY News RUBY Articles RUBY Message Board
Get RUBY Alerts

News, Short Squeeze, Breakout and More Instantly...